Guest: Dr. Scott Donaldson, Professor of Medicine, Pulmonary Diseases and Critical Care Medicine, UNC Chapel Hill; Associate Director, Marsico Clinical and Translational Research Center; Director, UNC Adult CF Care Center
Topics: Breakthrough new treatment for cystic fibrosis, CF diagnostics, other new CF therapies, CFTR mutations

Dr. Scott Donaldson

FDA approves new breakthrough therapy for cystic fibrosis

“Long-awaited cystic fibrosis drug could turn deadly disease into a manageable condition” Washington Post, October 31, 2019

UNC Adult Cystic Fibrosis Center

Scott’s Department of Medicine faculty page

Click to Download: Radio In Vivo February 5, 2020